Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-03-09

Clinical Trial Update: Sulforaphane Supplementation in Atopic Asthmatics [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating sulforaphane supplementation in individuals with atopic asthma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sulforaphane (sulforaphane)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Asthma | Phase 1 | Status: COMPLETED